...
首页> 外文期刊>Analytical chemistry >Validation and Application of a Method for the Determination of Buprenorphine,Norbuprenorphine,and Their Glucuronide Conjugates in Human Meconium
【24h】

Validation and Application of a Method for the Determination of Buprenorphine,Norbuprenorphine,and Their Glucuronide Conjugates in Human Meconium

机译:测定人胎粪中丁丙诺啡,去甲丁丙诺啡及其葡糖苷酸结合物的方法的验证和应用

获取原文
获取原文并翻译 | 示例

摘要

A novel liquid chromatography tandem mass spectrometry method for quantification of buprenorphine,norbuprenorphine,and glucuronidated conjugates was developed and validated.Analytes were extracted from meconium using buffer,concentrated by solid-phase extraction and quantified within 13.5 min.In order to determine free and total concentrations,specimens were analyzed with and without enzyme hydrolysis.Calibration was achieved by linear regression with a 1/x weighting factor and deuterated internal standards.All analytes were linear from 20 to 2000 ng/g with a correlation of determination of >0.98.Accuracy was >85.7% with intra-assay and interassay imprecision < 13.9 and 12.4%,respectively.There was no interference from 70 licit and illicit drugs and metabolites.Buffer extraction followed by SPE yielded recoveries of >85.0%.There was suppression of ionization by the polar matrix;however,this did not interfere with sensitivity or analyte quantification due to inclusion of deuterated internal standards.Analytes were stable on the autosam-pler,at room temperature,at 4 °C,and when exposed to three freeze/thaw cycles.This sensitive and specific method can be used to monitor in utero buprenorphine exposure and to evaluate correlations,if any,between buprenorphine exposure and neonatal outcomes.
机译:开发并验证了一种新的液相色谱串联质谱法,用于定量丁丙诺啡,去甲丁丙诺啡和葡糖醛酸化的缀合物。使用缓冲液从胎粪中提取分析物,通过固相萃取进行浓缩,并在13.5分钟内进行定量。浓度,标本在有或没有酶水解的情况下进行分析。使用1 / x权重因子和氘代内标通过线性回归进行校准。所有分析物在20至2000 ng / g之间呈线性关系,测定相关度> 0.98。批内和批间不精密度分别为> 85.7%和<13.9%和12.4%.70种合法和非法药物和代谢产物均无干扰;缓冲液提取后SPE回收率> 85.0%。极性基质;但是,由于包含氘代中间体,因此不会干扰灵敏度或分析物定量常规标准。在自动采样仪上,在室温下,在4°C下以及暴露于三个冷冻/融化循环时,分析物均稳定。这种灵敏而特异的方法可用于监测子宫丁丙诺啡的暴露并评估相关性,丁丙诺啡暴露与新生儿结局之间(如果有)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号